No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Tekamlo is a brand of cardiovascular drug developed by AstraZeneca. It is a combination of two drugs, amlodipine and aliskiren, which are used to treat high blood pressure. Tekamlo works by blocking calcium channels in the body, which helps to relax the blood vessels and reduce blood pressure. It is also used to reduce the risk of stroke, heart attack, and other cardiovascular events. Tekamlo is available in both tablet and capsule form and is taken once daily.
Tekamlo is a relatively new drug on the market, but it has already gained a significant following among physicians and patients. It is generally well-tolerated and has been shown to be effective in reducing blood pressure. Tekamlo is also cost-effective, making it an attractive option for those who need to manage their blood pressure.
Some of the companies in the Tekamlo market include AstraZeneca, Novartis, Merck, and Pfizer. Show Less Read more
